News
Obeldesivir provided faster symptom relief but did not reduce hospitalization or all-cause mortality in high-risk nonhospitalized patients with COVID-19.
The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...
According to the Cleveland Clinic, an American nonprofit academic medical centre, an mRNA vaccine trains your body to fight ...
In the video posted on X, Kennedy claimed mRNA vaccines were ineffective against mutated versions of the virus and revealed HHS is planning to reallocate the funding to research whole-virus vaccines, ...
The quest for a vaccine against HIV has been going on for about 40 years — almost as long as the virus that causes AIDS has ...
A study of over 10,000 nasal swabs finds that recent rhinovirus infections, the main cause of the common cold, reduce the ...
14d
Best Life on MSNScientists Make Breakthrough Discovery to Diagnose Long COVID
However, Stringer and a team of scientists believe they’re on the precipice of identifying a potential long COVID biomarker.
Study finds first specific and quantifiable indicator that may help develop better diagnostics and potential treatments US ...
6d
News-Medical.Net on MSNCOVID-19 accelerates vascular aging in women
Research shows COVID-19 accelerates vascular aging, especially in women, with implications for long-term cardiovascular ...
Researchers discovered viral fragments in blood samples from long COVID patients, hinting at a possible biomarker. The ...
During the COVID-19 pandemic, pharmaceutical companies produced unprecedented quantities of vaccines. This helped save ...
RFK Jr. recently made major cuts to mRNA vaccine development research, questioning their safety. Should you still get the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results